MS-DRG 820 - LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITH MCC

Lymphoma and Leukemia with Major Procedure

ICD-10-CM - Medical
ICD-10-PCS - Surgical

Principal Diagnosis - Pdx

C91.51 Adult T-cell lymphoma/leukemia (HTLV-1-associated), in remission
C91.52 Adult T-cell lymphoma/leukemia (HTLV-1-associated), in relapse
C91.60 Prolymphocytic leukemia of T-cell type not having achieved remission
C91.61 Prolymphocytic leukemia of T-cell type, in remission
C91.62 Prolymphocytic leukemia of T-cell type, in relapse
C91.90 Lymphoid leukemia, unspecified not having achieved remission
C91.91 Lymphoid leukemia, unspecified, in remission
C91.92 Lymphoid leukemia, unspecified, in relapse
C91.A0 Mature B-cell leukemia Burkitt-type not having achieved remission
C91.A1 Mature B-cell leukemia Burkitt-type, in remission
C91.A2 Mature B-cell leukemia Burkitt-type, in relapse
C91.Z0 Other lymphoid leukemia not having achieved remission
C91.Z1 Other lymphoid leukemia, in remission
C91.Z2 Other lymphoid leukemia, in relapse
C92.00 Acute myeloblastic leukemia, not having achieved remission
C92.01 Acute myeloblastic leukemia, in remission
C92.02 Acute myeloblastic leukemia, in relapse
C92.10 Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission
C92.11 Chronic myeloid leukemia, BCR/ABL-positive, in remission
C92.12 Chronic myeloid leukemia, BCR/ABL-positive, in relapse
C92.20 Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission
C92.21 Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission
C92.22 Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse
C92.30 Myeloid sarcoma, not having achieved remission
C92.31 Myeloid sarcoma, in remission
C92.32 Myeloid sarcoma, in relapse
C92.40 Acute promyelocytic leukemia, not having achieved remission
C92.41 Acute promyelocytic leukemia, in remission
C92.42 Acute promyelocytic leukemia, in relapse
C92.50 Acute myelomonocytic leukemia, not having achieved remission
C92.51 Acute myelomonocytic leukemia, in remission
C92.52 Acute myelomonocytic leukemia, in relapse
C92.60 Acute myeloid leukemia with 11q23-abnormality not having achieved remission
C92.61 Acute myeloid leukemia with 11q23-abnormality in remission
C92.62 Acute myeloid leukemia with 11q23-abnormality in relapse
C92.90 Myeloid leukemia, unspecified, not having achieved remission
C92.91 Myeloid leukemia, unspecified in remission
C92.92 Myeloid leukemia, unspecified in relapse
C92.A0 Acute myeloid leukemia with multilineage dysplasia, not having achieved remission
C92.A1 Acute myeloid leukemia with multilineage dysplasia, in remission
C92.A2 Acute myeloid leukemia with multilineage dysplasia, in relapse
C92.Z0 Other myeloid leukemia not having achieved remission
C92.Z1 Other myeloid leukemia, in remission
C92.Z2 Other myeloid leukemia, in relapse
C93.00 Acute monoblastic/monocytic leukemia, not having achieved remission
C93.01 Acute monoblastic/monocytic leukemia, in remission
C93.02 Acute monoblastic/monocytic leukemia, in relapse
C93.10 Chronic myelomonocytic leukemia not having achieved remission
C93.11 Chronic myelomonocytic leukemia, in remission
C93.12 Chronic myelomonocytic leukemia, in relapse
C93.30 Juvenile myelomonocytic leukemia, not having achieved remission
C93.31 Juvenile myelomonocytic leukemia, in remission
C93.32 Juvenile myelomonocytic leukemia, in relapse
C93.90 Monocytic leukemia, unspecified, not having achieved remission
C93.91 Monocytic leukemia, unspecified in remission
C93.92 Monocytic leukemia, unspecified in relapse
C93.Z0 Other monocytic leukemia, not having achieved remission
C93.Z1 Other monocytic leukemia, in remission
C93.Z2 Other monocytic leukemia, in relapse
C94.00 Acute erythroid leukemia, not having achieved remission
C94.01 Acute erythroid leukemia, in remission
C94.02 Acute erythroid leukemia, in relapse
C94.20 Acute megakaryoblastic leukemia not having achieved remission
C94.21 Acute megakaryoblastic leukemia, in remission
C94.22 Acute megakaryoblastic leukemia, in relapse
C94.30 Mast cell leukemia not having achieved remission
C94.31 Mast cell leukemia, in remission
C94.32 Mast cell leukemia, in relapse
C94.40 Acute panmyelosis with myelofibrosis not having achieved remission
C94.41 Acute panmyelosis with myelofibrosis, in remission
C94.42 Acute panmyelosis with myelofibrosis, in relapse
C94.6 Myelodysplastic disease, not elsewhere classified
C94.80 Other specified leukemias not having achieved remission
C94.81 Other specified leukemias, in remission
C94.82 Other specified leukemias, in relapse
C95.00 Acute leukemia of unspecified cell type not having achieved remission
C95.01 Acute leukemia of unspecified cell type, in remission
C95.02 Acute leukemia of unspecified cell type, in relapse
C95.10 Chronic leukemia of unspecified cell type not having achieved remission
C95.11 Chronic leukemia of unspecified cell type, in remission
C95.12 Chronic leukemia of unspecified cell type, in relapse
C95.90 Leukemia, unspecified not having achieved remission
C95.91 Leukemia, unspecified, in remission
C95.92 Leukemia, unspecified, in relapse
C96.20 Malignant mast cell neoplasm, unspecified
C96.21 Aggressive systemic mastocytosis
C96.22 Mast cell sarcoma
C96.29 Other malignant mast cell neoplasm
C96.4 Sarcoma of dendritic cells (accessory cells)
C96.9 Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified
C96.A Histiocytic sarcoma
C96.Z Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue
D45 Polycythemia vera
D47.01 Cutaneous mastocytosis
D47.02 Systemic mastocytosis
D47.09 Other mast cell neoplasms of uncertain behavior
D47.1 Chronic myeloproliferative disease
D47.9 Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified
D47.Z2 Castleman disease
D47.Z9 Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue

Operating / Non-Operating Room Procedures

0016070 Bypass Cerebral Ventricle to Nasopharynx with Autologous Tissue Substitute, Open Approach
0016071 Bypass Cerebral Ventricle to Mastoid Sinus with Autologous Tissue Substitute, Open Approach
0016072 Bypass Cerebral Ventricle to Atrium with Autologous Tissue Substitute, Open Approach
0016073 Bypass Cerebral Ventricle to Blood Vessel with Autologous Tissue Substitute, Open Approach
0016074 Bypass Cerebral Ventricle to Pleural Cavity with Autologous Tissue Substitute, Open Approach
0016075 Bypass Cerebral Ventricle to Intestine with Autologous Tissue Substitute, Open Approach
0016076 Bypass Cerebral Ventricle to Peritoneal Cavity with Autologous Tissue Substitute, Open Approach
0016077 Bypass Cerebral Ventricle to Urinary Tract with Autologous Tissue Substitute, Open Approach
0016078 Bypass Cerebral Ventricle to Bone Marrow with Autologous Tissue Substitute, Open Approach
001607B Bypass Cerebral Ventricle to Cerebral Cisterns with Autologous Tissue Substitute, Open Approach
00160J0 Bypass Cerebral Ventricle to Nasopharynx with Synthetic Substitute, Open Approach
00160J1 Bypass Cerebral Ventricle to Mastoid Sinus with Synthetic Substitute, Open Approach
00160J2 Bypass Cerebral Ventricle to Atrium with Synthetic Substitute, Open Approach
00160J3 Bypass Cerebral Ventricle to Blood Vessel with Synthetic Substitute, Open Approach
00160J4 Bypass Cerebral Ventricle to Pleural Cavity with Synthetic Substitute, Open Approach
00160J5 Bypass Cerebral Ventricle to Intestine with Synthetic Substitute, Open Approach
00160J6 Bypass Cerebral Ventricle to Peritoneal Cavity with Synthetic Substitute, Open Approach
00160J7 Bypass Cerebral Ventricle to Urinary Tract with Synthetic Substitute, Open Approach
00160J8 Bypass Cerebral Ventricle to Bone Marrow with Synthetic Substitute, Open Approach
00160JB Bypass Cerebral Ventricle to Cerebral Cisterns with Synthetic Substitute, Open Approach
00160K0 Bypass Cerebral Ventricle to Nasopharynx with Nonautologous Tissue Substitute, Open Approach
00160K1 Bypass Cerebral Ventricle to Mastoid Sinus with Nonautologous Tissue Substitute, Open Approach
00160K2 Bypass Cerebral Ventricle to Atrium with Nonautologous Tissue Substitute, Open Approach
00160K3 Bypass Cerebral Ventricle to Blood Vessel with Nonautologous Tissue Substitute, Open Approach
00160K4 Bypass Cerebral Ventricle to Pleural Cavity with Nonautologous Tissue Substitute, Open Approach
00160K5 Bypass Cerebral Ventricle to Intestine with Nonautologous Tissue Substitute, Open Approach
00160K6 Bypass Cerebral Ventricle to Peritoneal Cavity with Nonautologous Tissue Substitute, Open Approach
00160K7 Bypass Cerebral Ventricle to Urinary Tract with Nonautologous Tissue Substitute, Open Approach
00160K8 Bypass Cerebral Ventricle to Bone Marrow with Nonautologous Tissue Substitute, Open Approach
00160KB Bypass Cerebral Ventricle to Cerebral Cisterns with Nonautologous Tissue Substitute, Open Approach
0016370 Bypass Cerebral Ventricle to Nasopharynx with Autologous Tissue Substitute, Percutaneous Approach
0016371 Bypass Cerebral Ventricle to Mastoid Sinus with Autologous Tissue Substitute, Percutaneous Approach
0016372 Bypass Cerebral Ventricle to Atrium with Autologous Tissue Substitute, Percutaneous Approach
0016373 Bypass Cerebral Ventricle to Blood Vessel with Autologous Tissue Substitute, Percutaneous Approach
0016374 Bypass Cerebral Ventricle to Pleural Cavity with Autologous Tissue Substitute, Percutaneous Approach
0016375 Bypass Cerebral Ventricle to Intestine with Autologous Tissue Substitute, Percutaneous Approach
0016376 Bypass Cerebral Ventricle to Peritoneal Cavity with Autologous Tissue Substitute, Percutaneous Approach
0016377 Bypass Cerebral Ventricle to Urinary Tract with Autologous Tissue Substitute, Percutaneous Approach
0016378 Bypass Cerebral Ventricle to Bone Marrow with Autologous Tissue Substitute, Percutaneous Approach
001637B Bypass Cerebral Ventricle to Cerebral Cisterns with Autologous Tissue Substitute, Percutaneous Approach
00163J0 Bypass Cerebral Ventricle to Nasopharynx with Synthetic Substitute, Percutaneous Approach
00163J1 Bypass Cerebral Ventricle to Mastoid Sinus with Synthetic Substitute, Percutaneous Approach
00163J2 Bypass Cerebral Ventricle to Atrium with Synthetic Substitute, Percutaneous Approach
00163J3 Bypass Cerebral Ventricle to Blood Vessel with Synthetic Substitute, Percutaneous Approach
00163J4 Bypass Cerebral Ventricle to Pleural Cavity with Synthetic Substitute, Percutaneous Approach
00163J5 Bypass Cerebral Ventricle to Intestine with Synthetic Substitute, Percutaneous Approach
00163J6 Bypass Cerebral Ventricle to Peritoneal Cavity with Synthetic Substitute, Percutaneous Approach
00163J7 Bypass Cerebral Ventricle to Urinary Tract with Synthetic Substitute, Percutaneous Approach
00163J8 Bypass Cerebral Ventricle to Bone Marrow with Synthetic Substitute, Percutaneous Approach
00163JB Bypass Cerebral Ventricle to Cerebral Cisterns with Synthetic Substitute, Percutaneous Approach
00163K0 Bypass Cerebral Ventricle to Nasopharynx with Nonautologous Tissue Substitute, Percutaneous Approach
00163K1 Bypass Cerebral Ventricle to Mastoid Sinus with Nonautologous Tissue Substitute, Percutaneous Approach
00163K2 Bypass Cerebral Ventricle to Atrium with Nonautologous Tissue Substitute, Percutaneous Approach
00163K3 Bypass Cerebral Ventricle to Blood Vessel with Nonautologous Tissue Substitute, Percutaneous Approach
00163K4 Bypass Cerebral Ventricle to Pleural Cavity with Nonautologous Tissue Substitute, Percutaneous Approach
00163K5 Bypass Cerebral Ventricle to Intestine with Nonautologous Tissue Substitute, Percutaneous Approach
00163K6 Bypass Cerebral Ventricle to Peritoneal Cavity with Nonautologous Tissue Substitute, Percutaneous Approach
00163K7 Bypass Cerebral Ventricle to Urinary Tract with Nonautologous Tissue Substitute, Percutaneous Approach
00163K8 Bypass Cerebral Ventricle to Bone Marrow with Nonautologous Tissue Substitute, Percutaneous Approach
00163KB Bypass Cerebral Ventricle to Cerebral Cisterns with Nonautologous Tissue Substitute, Percutaneous Approach
0016470 Bypass Cerebral Ventricle to Nasopharynx with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
0016471 Bypass Cerebral Ventricle to Mastoid Sinus with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
0016472 Bypass Cerebral Ventricle to Atrium with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
0016473 Bypass Cerebral Ventricle to Blood Vessel with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
0016474 Bypass Cerebral Ventricle to Pleural Cavity with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
0016475 Bypass Cerebral Ventricle to Intestine with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
0016476 Bypass Cerebral Ventricle to Peritoneal Cavity with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
0016477 Bypass Cerebral Ventricle to Urinary Tract with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
0016478 Bypass Cerebral Ventricle to Bone Marrow with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
001647B Bypass Cerebral Ventricle to Cerebral Cisterns with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
00164J0 Bypass Cerebral Ventricle to Nasopharynx with Synthetic Substitute, Percutaneous Endoscopic Approach
00164J1 Bypass Cerebral Ventricle to Mastoid Sinus with Synthetic Substitute, Percutaneous Endoscopic Approach
00164J2 Bypass Cerebral Ventricle to Atrium with Synthetic Substitute, Percutaneous Endoscopic Approach
00164J3 Bypass Cerebral Ventricle to Blood Vessel with Synthetic Substitute, Percutaneous Endoscopic Approach
00164J4 Bypass Cerebral Ventricle to Pleural Cavity with Synthetic Substitute, Percutaneous Endoscopic Approach
00164J5 Bypass Cerebral Ventricle to Intestine with Synthetic Substitute, Percutaneous Endoscopic Approach
00164J6 Bypass Cerebral Ventricle to Peritoneal Cavity with Synthetic Substitute, Percutaneous Endoscopic Approach
00164J7 Bypass Cerebral Ventricle to Urinary Tract with Synthetic Substitute, Percutaneous Endoscopic Approach
00164J8 Bypass Cerebral Ventricle to Bone Marrow with Synthetic Substitute, Percutaneous Endoscopic Approach
00164JB Bypass Cerebral Ventricle to Cerebral Cisterns with Synthetic Substitute, Percutaneous Endoscopic Approach
00164K0 Bypass Cerebral Ventricle to Nasopharynx with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
00164K1 Bypass Cerebral Ventricle to Mastoid Sinus with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
00164K2 Bypass Cerebral Ventricle to Atrium with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
00164K3 Bypass Cerebral Ventricle to Blood Vessel with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
00164K4 Bypass Cerebral Ventricle to Pleural Cavity with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
00164K5 Bypass Cerebral Ventricle to Intestine with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
00164K6 Bypass Cerebral Ventricle to Peritoneal Cavity with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
00164K7 Bypass Cerebral Ventricle to Urinary Tract with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
00164K8 Bypass Cerebral Ventricle to Bone Marrow with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
00164KB Bypass Cerebral Ventricle to Cerebral Cisterns with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
001U072 Bypass Spinal Canal to Atrium with Autologous Tissue Substitute, Open Approach
001U074 Bypass Spinal Canal to Pleural Cavity with Autologous Tissue Substitute, Open Approach
001U076 Bypass Spinal Canal to Peritoneal Cavity with Autologous Tissue Substitute, Open Approach
001U077 Bypass Spinal Canal to Urinary Tract with Autologous Tissue Substitute, Open Approach
001U079 Bypass Spinal Canal to Fallopian Tube with Autologous Tissue Substitute, Open Approach
001U0J2 Bypass Spinal Canal to Atrium with Synthetic Substitute, Open Approach
001U0J4 Bypass Spinal Canal to Pleural Cavity with Synthetic Substitute, Open Approach
001U0J6 Bypass Spinal Canal to Peritoneal Cavity with Synthetic Substitute, Open Approach
001U0J7 Bypass Spinal Canal to Urinary Tract with Synthetic Substitute, Open Approach
001U0J9 Bypass Spinal Canal to Fallopian Tube with Synthetic Substitute, Open Approach